EP Patent

EP3777832A1 — Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof

Assigned to Atnx Spv LLC · Expires 2021-02-17 · 5y expired

What this patent protects

The invention relates to a pharmaceutical composition comprising 2-(5-(4-(2-mopholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

USPTO Abstract

The invention relates to a pharmaceutical composition comprising 2-(5-(4-(2-mopholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

Drugs covered by this patent

Patent Metadata

Patent number
EP3777832A1
Jurisdiction
EP
Classification
—
Expires
2021-02-17
Drug substance claim
No
Drug product claim
No
Assignee
Atnx Spv LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.